Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.
Focus (Am Psychiatr Publ) June 17, 2020 Franklin King, Rebecca Hammond 13 citations
Psychedelic-assisted psychotherapy is reemerging as a potential treatment for anxiety disorders, with accumulating evidence and likely FDA approval within 2-3 years. However, the field faces regulatory barriers, lack of clinician education, stigma, high costs, and a shortage of trained personnel. Ethical issues include responsibility toward indigenous peoples who historically used psychedelics and ongoing disparities in mental health access.